The researchers found that in men, but not in women, increasing CXCL9 levels were associated with an increasing risk for hip fracture. The odds ratios in the highest quartile compared with the lowest quartile were 10.35 (95 percent confidence interval, 1.90 to 56.39) and 1.46 (95 percent confidence interval, 0.59 to 3.60) in men and women, respectively.
Source: HealthDay
